Sign In
Buy NDAQ
$81.61
-0.88 (-1.07%)
At Close: Jun 24, 2026
T2 Biosystems Announces Closing of $8 Million Private Placement Priced At-The-Market Under Nasdaq Rules
04:05pm, Friday, 17'th May 2024
LEXINGTON, Mass., May 17, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that
Mesa Air Group Discloses Notice from Nasdaq
04:05pm, Friday, 17'th May 2024
PHOENIX, May 17, 2024 (GLOBE NEWSWIRE) -- Mesa Air Group, Inc. (NASDAQ: MESA) (“Mesa” or the “Company”) today announced that it received a notice (“Notice”) on May 16, 2024 from the Listin
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
04:05pm, Friday, 17'th May 2024
DALLAS--(BUSINESS WIRE)--Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Friday, 17'th May 2024
SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that on May 15, 2024, the Compensation Committee of Acadia's Board of Directors (the “Committee”) granted ind
Alpine 4 Holdings, Inc. Announces Receipt of Nasdaq Staff Determination Letter
04:00pm, Friday, 17'th May 2024
PHOENIX, AZ / ACCESSWIRE / May 17, 2024 / Alpine 4 Holdings, Inc (NASDAQ:ALPP) (the "Company"), announced today that on May 14, 2024, it received a Staff Delisting Determination letter (the "Staff Det
Dermata Therapeutics Announces Exercise of Warrants for $2.66 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules
08:30am, Friday, 17'th May 2024
SAN DIEGO, CA / ACCESSWIRE / May 17, 2024 / Dermata Therapeutics, Inc. (Nasdaq:DRMA)(Nasdaq:DRMAW) ("Dermata," or the "Company"), a late-stage biotechnology company focused on the treatment of medical
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08:05am, Friday, 17'th May 2024
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on April 22, 2024, the Compensation Committee of Guardant's Board of
Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
07:00am, Friday, 17'th May 2024
DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies f
Wall Street Favorites: 3 Nasdaq Stocks With Strong Buy Ratings for May 2024
06:00am, Friday, 17'th May 2024
The Nasdaq Composite index is at an all-time high after April's inflation rate came in weaker than expected and U.S. Federal Reserve Chair Jerome Powell reassured markets that further interest rate hi
NEW YORK , May 16, 2024 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL) ("Seelos" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of therapies for cen
RF Acquisition Corp II Announces Pricing of $100 Million Initial Public Offering
10:26pm, Thursday, 16'th May 2024
GRAND CAYMAN, Cayman Islands, May 16, 2024 (GLOBE NEWSWIRE) -- RF Acquisition Corp II (the “Company”) today announced the pricing of its initial public offering of 10,000,000 units at a price of $
Society Pass Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
11:17am, Thursday, 16'th May 2024
SINGAPORE, May 16, 2024 (GLOBE NEWSWIRE) -- Society Pass Inc. (NASDAQ: SOPA) (“SoPa” or the “Company”), a leading e-commerce ecosystem in Southeast Asia (“SEA”), announced a formal notific
Assure Announces it will Remain Listed on the Nasdaq Capital Market Pursuant to Nasdaq Panel Decision
09:44am, Thursday, 16'th May 2024
DENVER, May 16, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology servic
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05:00pm, Wednesday, 15'th May 2024
SAN DIEGO, May 15, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that on May 10, 2024, the Compensation Committee of its Board of Directors granted inducement eq
NEW YORK, May 15, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of Better Therapeutics, Inc. Better Therapeutics, Inc.'s securities were suspe
